(Total Views: 470)
Posted On: 07/26/2023 12:27:28 AM
Post# of 145881
Quote:
My understanding was that the 'AI capable partner' was for the purpose of developing a longer term therapeutic for Leronlimab... (not to find more indications to pursue)
You are correct. I should have listened to the CC first. Extending patent protection would also have the benefit of assuring any partners of a long runway for the drug.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)